Cargando…
Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency
Introduction: If a woman suffers from congenital fibrinogen deficiency (CFD), she might undergo hypermenorrhea monthly and possibly to suffer from hemoperitoneum due to a ruptured follicle or corpus luteal cyst every month, which seriously threaten her health and quality of life. Here, we creatively...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253637/ https://www.ncbi.nlm.nih.gov/pubmed/32509792 http://dx.doi.org/10.3389/fmed.2020.00181 |
_version_ | 1783539371164565504 |
---|---|
author | Wang, Yiran Zhao, Lanbo Feng, Xue Li, Qing Ma, Sijia Liang, Dongxin Liu, Mingge Yin, Panyue Li, Qiling Lu, Qinrui |
author_facet | Wang, Yiran Zhao, Lanbo Feng, Xue Li, Qing Ma, Sijia Liang, Dongxin Liu, Mingge Yin, Panyue Li, Qiling Lu, Qinrui |
author_sort | Wang, Yiran |
collection | PubMed |
description | Introduction: If a woman suffers from congenital fibrinogen deficiency (CFD), she might undergo hypermenorrhea monthly and possibly to suffer from hemoperitoneum due to a ruptured follicle or corpus luteal cyst every month, which seriously threaten her health and quality of life. Here, we creatively used a combination of the levonorgestrel-releasing intrauterine system (LNG-IUS) and the combined oral contraceptives (COC) for a girl with CFD. Case presentation: A 14-year-old girl presented with no obvious cause of persistent and severe lower abdominal pain that began 8 h prior. After examination, she was diagnosed as hemoperitoneum. CFD was diagnosed when she was 2 years old and she had two hospitalizations due to hemorrhagic anemia caused by menorrhagia. Therefore, after successful conservative treatment of hemoperitoneum, a combination of LNG-IUS and COC was used for the long-term conservative management of hypermenorrhea and hemoperitoneum. During the half-year of follow-up, she had hypomenorrhea without hemoperitoneum. Conclusions: To the best of our knowledge, this was the first patient treated with such a procedure in the literature, and we recommend every woman with CFD at puberty or reproductive age receives this two-pronged treatment. |
format | Online Article Text |
id | pubmed-7253637 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72536372020-06-05 Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency Wang, Yiran Zhao, Lanbo Feng, Xue Li, Qing Ma, Sijia Liang, Dongxin Liu, Mingge Yin, Panyue Li, Qiling Lu, Qinrui Front Med (Lausanne) Medicine Introduction: If a woman suffers from congenital fibrinogen deficiency (CFD), she might undergo hypermenorrhea monthly and possibly to suffer from hemoperitoneum due to a ruptured follicle or corpus luteal cyst every month, which seriously threaten her health and quality of life. Here, we creatively used a combination of the levonorgestrel-releasing intrauterine system (LNG-IUS) and the combined oral contraceptives (COC) for a girl with CFD. Case presentation: A 14-year-old girl presented with no obvious cause of persistent and severe lower abdominal pain that began 8 h prior. After examination, she was diagnosed as hemoperitoneum. CFD was diagnosed when she was 2 years old and she had two hospitalizations due to hemorrhagic anemia caused by menorrhagia. Therefore, after successful conservative treatment of hemoperitoneum, a combination of LNG-IUS and COC was used for the long-term conservative management of hypermenorrhea and hemoperitoneum. During the half-year of follow-up, she had hypomenorrhea without hemoperitoneum. Conclusions: To the best of our knowledge, this was the first patient treated with such a procedure in the literature, and we recommend every woman with CFD at puberty or reproductive age receives this two-pronged treatment. Frontiers Media S.A. 2020-05-21 /pmc/articles/PMC7253637/ /pubmed/32509792 http://dx.doi.org/10.3389/fmed.2020.00181 Text en Copyright © 2020 Wang, Zhao, Feng, Li, Ma, Liang, Liu, Yin, Li and Lu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Wang, Yiran Zhao, Lanbo Feng, Xue Li, Qing Ma, Sijia Liang, Dongxin Liu, Mingge Yin, Panyue Li, Qiling Lu, Qinrui Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency |
title | Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency |
title_full | Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency |
title_fullStr | Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency |
title_full_unstemmed | Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency |
title_short | Two-Pronged Treatment of Hemoperitoneum and Abnormal Uterine Bleeding in an Adolescent Girl With Congenital Fibrinogen Deficiency |
title_sort | two-pronged treatment of hemoperitoneum and abnormal uterine bleeding in an adolescent girl with congenital fibrinogen deficiency |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253637/ https://www.ncbi.nlm.nih.gov/pubmed/32509792 http://dx.doi.org/10.3389/fmed.2020.00181 |
work_keys_str_mv | AT wangyiran twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency AT zhaolanbo twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency AT fengxue twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency AT liqing twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency AT masijia twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency AT liangdongxin twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency AT liumingge twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency AT yinpanyue twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency AT liqiling twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency AT luqinrui twoprongedtreatmentofhemoperitoneumandabnormaluterinebleedinginanadolescentgirlwithcongenitalfibrinogendeficiency |